DEVELOP(SH:688377)2021-04-29 16:00Financial Performance - Operating income fell by 33.07% to CNY 121.39 million, primarily due to the impact of the COVID-19 pandemic[12] - Net profit attributable to shareholders decreased by 73.82% to CNY 6.26 million[5] - Total profit decreased by 55.11% to ¥13,750,366.12, driven by reduced sales revenue and increased costs[13] - Net profit fell by 55.49% to ¥12,060,379.03, reflecting a decline in operating profit[13] - Total revenue for Q1 2021 was CNY 121,393,845.67, a decrease of 32.98% compared to CNY 181,384,706.09 in Q1 2020[23] - Total operating costs for Q1 2021 were CNY 116,309,348.12, down 25.31% from CNY 155,697,449.47 in Q1 2020[23] - Net profit for Q1 2021 was CNY 12,060,379.03, a decline of 55.49% from CNY 27,097,873.23 in Q1 2020[24] - The total profit for Q1 2021 was CNY 16.73 million, down 48.5% from CNY 32.48 million in Q1 2020[27] Cash Flow - Cash flow from operating activities decreased by 48.84% to CNY 21.02 million[5] - Cash flow from operating activities decreased by 48.84% to ¥21,019,790.45, due to reduced cash received from sales[13] - The net cash flow from operating activities for Q1 2021 was CNY 21.02 million, a decline of 48.8% compared to CNY 41.09 million in Q1 2020[29] - Cash inflow from operating activities totaled CNY 174.21 million in Q1 2021, down 6.8% from CNY 186.95 million in Q1 2020[29] - The company incurred financial expenses of CNY 589.54 in Q1 2021, a significant decrease from CNY 928.77 million in Q1 2020[26] Assets and Liabilities - Total assets decreased by 0.59% to CNY 1,852.12 million compared to the end of the previous year[5] - Total assets as of March 31, 2021, were CNY 1,852,921,382.41, slightly down from CNY 1,858,738,108.22 at the end of 2020[21] - Total liabilities as of March 31, 2021, were CNY 296,612,324.45, a decrease from CNY 317,303,510.78 at the end of 2020[20] - Current liabilities decreased to ¥261,926,989.66 from ¥282,450,412.89, indicating improved liquidity management[17] Research and Development - R&D expenditure as a percentage of operating income decreased by 1.36 percentage points to 3.79%[5] - R&D expenses decreased by 50.71% to ¥4,603,643.52 due to reduced project investments[13] - The company reported a decrease in research and development expenses to CNY 4,603,643.52 in Q1 2021 from CNY 9,339,821.19 in Q1 2020[23] - Research and development expenses decreased to CNY 4.60 million in Q1 2021 from CNY 9.34 million in Q1 2020, representing a reduction of 50.8%[26] Government Support - The company received government subsidies amounting to CNY 424.83 million related to information technology and imported equipment[8] - The company reported a significant increase in other income by 102.73% to ¥4,248,333.33, due to increased government subsidies for information technology[13] Shareholder Information - The number of shareholders reached 11,911 at the end of the reporting period[10] Cash Management - The company's cash and cash equivalents increased to ¥235,821,328.73 from ¥192,367,565.20, reflecting better cash management[15] - Cash and cash equivalents increased to CNY 188,231,183.49 from CNY 179,832,512.02 at the end of 2020[20] - The company reported a significant increase in cash and cash equivalents, ending Q1 2021 with CNY 207.37 million, up from CNY 69.51 million at the end of Q1 2020[30] - The ending balance of cash and cash equivalents increased to ¥159,778,644.22, up from ¥65,915,363.22 at the end of Q1 2020[33]